Novartis AG - Company Profile and SWOT Analysis
SummaryNovartis AG - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Novartis AG (Novartis) is engaged in research, development, manufacturing, distribution, marketing, and sale of innovative medicines. It provides a diverse range of products across various therapeutic areas, including cardiovascular, renal and metabolic, immunology, ophthalmology, respiratory, global health, neuroscience, and oncology. Novartis distributes its products to a wide array of stakeholders, including pharmacists, private health systems, government agencies, physicians, hospitals, insurance groups, managed care providers, pharmacy benefit managers, and government-supported healthcare systems, under brands such as Entresto, Cosentyx, Kesimpta, Kisqali, and Tasigna, among others, on a global scale. It operates manufacturing facilities in the US, Switzerland, Austria, Slovenia, China, France, and Italy. Novartis is headquartered in Basel, Switzerland.
Scope
Novartis AG - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Novartis AG (Novartis) is engaged in research, development, manufacturing, distribution, marketing, and sale of innovative medicines. It provides a diverse range of products across various therapeutic areas, including cardiovascular, renal and metabolic, immunology, ophthalmology, respiratory, global health, neuroscience, and oncology. Novartis distributes its products to a wide array of stakeholders, including pharmacists, private health systems, government agencies, physicians, hospitals, insurance groups, managed care providers, pharmacy benefit managers, and government-supported healthcare systems, under brands such as Entresto, Cosentyx, Kesimpta, Kisqali, and Tasigna, among others, on a global scale. It operates manufacturing facilities in the US, Switzerland, Austria, Slovenia, China, France, and Italy. Novartis is headquartered in Basel, Switzerland.
Reasons To Buy
- Detailed information on Novartis AG required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Novartis AG in the form of a SWOT analysis
- An in-depth view of the business model of Novartis AG including a breakdown and examination of key business segments
- Intelligence on Novartis AG's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Novartis AG, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
MarketLine, a world-leading provider of commercial intelligence, has over 400 experienced analysts, consultants, and researchers with regional and sector expertise in market sizing, competitor tracking, socio and macro economics, and business drivers.
For more than 15 years MarketLine has supported the research needs of investment banks, corporations, professional services firms, and academia with a unique mix of company, industry, country, city and financial data for every major industry and marketplace.
MarketLine’ holistic business intelligence report collection includes:
Industry Intelligence
‒ Industry Profiles
‒ Market Forecasts
‒ Porter’s Five Forces Analysis
Company Intelligence
‒ Company Profiles
‒ SWOT Analysis
‒ Financial Deals
Country and City Intelligence
‒ Country and City Profiles
‒ PEST/PESTLE Analysis
‒ Socio and macro-economic indicators
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.